Why unannounced audits may spell the end of PVC-based plastics in medical devices
This article was originally published in Clinica
EU manufacturers may wish to consider phasing out the use of PVC in the manufacture of their medical devices, or risk exorbitant costs linked to unannounced audits by notified bodies in far flung places. That is the view of Andy Vaughan, consultant (standards) to the Association of British Healthcare Industries.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.